CoChat

Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase

Open access
Yoneyama, Yosuke, Inamitsu, Tomomi, Chida, Kazuhiro, Iemura, Shun-Ichiro, Natsume, Tohru, Maeda, Tatsuya, Hakuno, Fumihiko, Takahashi, Shin-Ichiro · 2018 · iScience
Cited by 85

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

The insulin receptor substrate IRS-1 is a key substrate of insulin and insulin-like growth factor (IGF) receptor tyrosine kinases that mediates their metabolic and growth-promoting actions. Proteasomal degradation of IRS-1 is induced following activation of the downstream kinase mTOR complex 1 (mTORC1) to constitute a negative feedback loop. However, the underlying mechanism remains poorly understood. Here we report that Ser 422 of IRS-1 is phosphorylated by mTORC1 and required for IRS-1 degradation induced by prolonged IGF stimulation. Phosphorylation of Ser 422 then recruits the SCFβ-TRCP E3 ligase complex, which catalyzes IRS-1 ubiquitination. Phosphorylation-dependent IRS-1 degradation contributes to impaired growth and survival responses to IGF in cells lacking TSC2, a negative regulator of mTORC1. Inhibition of IRS-1 degradation promotes sustained Akt activation in IGF-stimulated cells. Our work clarifies the nature of the IRS-1-mTORC1 feedback loop and elucidates its role in temporal regulation of IGF signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.isci.2018.06.006

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 42

  1. Ardestani, 2018, mTORC1 signaling: a double-edged sword in diabetic β cells, Cell Metab., 27, 314, 10.1016/j.cmet.2017.11.004 · DOI · Paper page
  2. Berg, 2002, Rapamycin partially prevents insulin resistance induced by chronic insulin treatment, Biochem. Biophys. Res. Commun., 293, 1021, 10.1016/S0006-291X(02)00333-9 · DOI
  3. Ding, 2016, Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling, Nat. Cell Biol., 18, 319, 10.1038/ncb3311 · DOI
  4. Frescas, 2008, Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer, Nat. Rev. Cancer, 8, 438, 10.1038/nrc2396 · DOI · Paper page
  5. Gross, 2016, Mapping growth-factor-modulated Akt signaling dynamics, J. Cell Sci., 129, 2052, 10.1242/jcs.183764 · DOI
  6. Harrington, 2004, The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins, J. Cell Biol., 166, 213, 10.1083/jcb.200403069 · DOI · Paper page
  7. Harrington, 2005, Restraining PI3K: mTOR signalling goes back to the membrane, Trends Biochem. Sci., 30, 35, 10.1016/j.tibs.2004.11.003 · DOI · Paper page
  8. Hartley, 2002, Role of mTOR in the degradation of IRS-1: regulation of PP2A activity, J. Cell. Biochem., 85, 304, 10.1002/jcb.10135 · DOI · Paper page
  9. Haruta, 2000, A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1, Mol. Endocrinol., 14, 783, 10.1210/mend.14.6.0446 · DOI · Paper page
  10. Hoehn, 2008, IRS1-independent defects define major nodes of insulin resistance, Cell Metab., 7, 421, 10.1016/j.cmet.2008.04.005 · DOI · Paper page
  11. Hornbeck, 2015, PhosphoSitePlus, 2014: mutations, PTMs and recalibrations, Nucleic Acids Res., 43, D512, 10.1093/nar/gku1267 · DOI · Paper page
  12. Hsu, 2011, The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling, Science, 332, 1317, 10.1126/science.1199498 · DOI · Paper page
  13. Huang, 2005, Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in L6 myotubes, J. Biol. Chem., 280, 19426, 10.1074/jbc.M412317200 · DOI · Paper page
  14. Humphrey, 2013, Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2, Cell Metab., 17, 1009, 10.1016/j.cmet.2013.04.010 · DOI · Paper page
  15. Kim, 2002, mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery, Cell, 110, 163, 10.1016/S0092-8674(02)00808-5 · DOI · Paper page
  16. Kim, 2012, mTOR complex 2 regulates proper turnover of insulin receptor Substrate-1 via the ubiquitin ligase subunit Fbw8, Mol. Cell, 48, 875, 10.1016/j.molcel.2012.09.029 · DOI · Paper page
  17. Kubota, 2012, Temporal coding of insulin action through multiplexing of the AKT pathway, Mol. Cell, 46, 820, 10.1016/j.molcel.2012.04.018 · DOI
  18. Lee, 2000, Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3’-kinase inhibition, Mol. Cell. Biol., 20, 1489, 10.1128/MCB.20.5.1489-1496.2000 · DOI · Paper page
  19. Liu, 2013, Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis, Nat. Cell Biol., 15, 1340, 10.1038/ncb2860 · DOI · Paper page
  20. Ma, 2009, Molecular mechanisms of mTOR-mediated translational control, Nat. Rev. Mol. Cell Biol., 10, 307, 10.1038/nrm2672 · DOI · Paper page
  21. Menon, 2014, Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome, Cell, 156, 771, 10.1016/j.cell.2013.11.049 · DOI · Paper page
  22. Menon, 2008, Common corruption of the mTOR signaling network in human tumors, Oncogene, 27, S43, 10.1038/onc.2009.352 · DOI · Paper page
  23. Myers, 1996, YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites, Mol. Cell. Biol., 16, 4147, 10.1128/MCB.16.8.4147 · DOI · Paper page
  24. Nakae, 2001, Distinct and overlapping functions of insulin and IGF-I receptors, Endocr. Rev., 22, 818, 10.1210/edrv.22.6.0452 · DOI · Paper page
  25. Nakao, 2009, Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading, Mol. Cell. Biol., 29, 4798, 10.1128/MCB.01347-08 · DOI · Paper page
  26. Ohne, 2008, Isolation of hyperactive mutants of mammalian target of rapamycin, J. Biol. Chem., 283, 31861, 10.1074/jbc.M801546200 · DOI · Paper page
  27. Pearce, 2010, Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1), Biochem. J., 431, 245, 10.1042/BJ20101024 · DOI · Paper page
  28. Rodrik-Outmezguine, 2011, mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling, Cancer Discov., 1, 248, 10.1158/2159-8290.CD-11-0085 · DOI · Paper page
  29. Sarbassov, 2006, Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB, Mol. Cell, 22, 159, 10.1016/j.molcel.2006.03.029 · DOI · Paper page
  30. Shah, 2004, Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies, Curr. Biol., 14, 1650, 10.1016/j.cub.2004.08.026 · DOI · Paper page
  31. Shi, 2011, The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling, Dev. Cell, 21, 835, 10.1016/j.devcel.2011.09.011 · DOI
  32. Sun, 1993, Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1, Mol. Cell. Biol., 13, 7418
  33. Tzatsos, 2009, Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR, J. Biol. Chem., 284, 22525, 10.1074/jbc.M109.027748 · DOI · Paper page
  34. Usui, 2004, β-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1, Mol. Cell. Biol., 24, 8929, 10.1128/MCB.24.20.8929-8937.2004 · DOI · Paper page
  35. Wan, 2007, Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism, Oncogene, 26, 1932, 10.1038/sj.onc.1209990 · DOI · Paper page
  36. Wang, 2014, Roles of F-box proteins in cancer, Nat. Rev. Cancer, 14, 233, 10.1038/nrc3700 · DOI · Paper page
  37. Xu, 2008, The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation, Mol. Cell, 30, 403, 10.1016/j.molcel.2008.03.009 · DOI · Paper page
  38. Yi, 2013, MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling, Nat. Commun., 4, 2354, 10.1038/ncomms3354 · DOI · Paper page
  39. Yoneyama, 2018, IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling, Elife, 7, 10.7554/eLife.32893 · DOI
  40. Yoneyama, 2013, The AP-1 complex regulates intracellular localization of insulin receptor substrate 1, which is required for insulin-like growth factor I-dependent cell proliferation, Mol. Cell. Biol., 33, 1991, 10.1128/MCB.01394-12 · DOI
  41. Yoon, 2017, Focal adhesion- and IGF1R-dependent survival and migratory pathways mediate tumor resistance to mTORC1/2 inhibition, Mol. Cell, 67, 512, 10.1016/j.molcel.2017.06.033 · DOI · Paper page
  42. Yu, 2011, Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling, Science, 332, 1322, 10.1126/science.1199484 · DOI · Paper page

Cited by

See all 85

Metadata

Authors
Yoneyama, Y., Inamitsu, T., Chida, K., Iemura, S.-I., Natsume, T., Maeda, T., Hakuno, F., & Takahashi, S.-I.
Venue
iScience
Publisher
Elsevier BV
Published
2018-07
Volume
5
Pages
1-18
ISSN
2589-0042 (ISSN-L)
OpenAlex
W2808704302
Cited by
85
References
12
FWCI
3.14
Type
journal article
Language
en
Open access
gold
Licence
Funders
Japan Society for the Promotion of Science (18H03972, 17H03802, 15K18766, 25221204)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. https://app.cochat.ai/papers/10.1016/j.isci.2018.06.006
The paper
Yoneyama, Y., Inamitsu, T., Chida, K., Iemura, S.-I., Natsume, T., Maeda, T., Hakuno, F., & Takahashi, S.-I. (2018). Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. iScience. https://doi.org/10.1016/j.isci.2018.06.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.